Skip to main content

Year: 2021

Formula Systems Reports Third Quarter 2021 Financial Results

Or Yehuda, Israel, Nov. 18, 2021 (GLOBE NEWSWIRE) — Formula Systems (1985) Ltd. (NASDAQ: FORTY), a global information technology holding company engaged, through its subsidiaries and affiliates, in providing software consulting services and computer-based business solutions and developing proprietary software products, today announced its results for the third quarter and nine-month period ended September 30, 2021. Financial Highlights for the Third Quarter Ended September 30, 2021  ● Consolidated revenues for the third quarter ended September 30, 2021 increased by 20.3% to $586.3 million, with growth recorded across Formula’s entire investment portfolio, compared to $487.3 million in the same period last year.       ● Consolidated operating income for the third quarter ended September 30, 2021 increased by 11.2% to $50.5...

Continue reading

Teleflex Earns Top Spot in MedReps Best Places to Work 2022 Ranking

WAYNE, Pa., Nov. 18, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, has announced it was named a winner in the MedReps.com Best Places to Work in Medical Sales 2022 survey, earning the Number 1 spot for large companies and making this the fifth consecutive year the company has been on the list. MedReps surveyed over 2,300 medical sales professionals, asking responders to rank their most desirable medical device companies and to rank the qualities and values most important to medical sales reps. In this year’s results, pay, leadership and culture ranked among the most important considerations in selecting an employer. “We are pleased to receive this award, which reflects our strong culture and core values,” said Liam Kelly, Chairman, President, and CEO. “Teleflex’s people...

Continue reading

Lands’ End Announces Third Quarter Fiscal 2021 Earnings Conference Call

DODGEVILLE, Wis., Nov. 18, 2021 (GLOBE NEWSWIRE) — Lands’ End, Inc. (NASDAQ: LE) will host a conference call at 8:30 a.m. Eastern Time on Thursday, December 2, 2021, to discuss its third quarter fiscal 2021 financial results. A news release containing these results will be issued before the call. Listeners may access a live broadcast of the conference call on the Company’s investor relations website: http://investors.landsend.com/ in the Events and Presentations section or by dialing (866) 753-5836. An online archive of the broadcast will be available at approximately noon on December 2, 2021, and will be accessible on the Company’s website: http://investors.landsend.com/ in the Events and Presentations section. About Lands’ End, Inc. Lands’ End, Inc. (NASDAQ:LE) is a leading uni-channel retailer of casual clothing,...

Continue reading

Bilibili Inc. Announces Proposed Offering of US$1,400 Million Convertible Senior Notes

SHANGHAI, China, Nov. 18, 2021 (GLOBE NEWSWIRE) — Bilibili Inc. (“Bilibili” or the “Company”) (NASDAQ: BILI and HKEX: 9626), an iconic brand and a leading video community for young generations in China, today announced a proposed offering (the “Notes Offering”) of US$1,400 million in aggregate principal amount of convertible senior notes due 2026 (the “Notes”) subject to market conditions and other factors. The Company intends to grant the initial purchasers in the Notes Offering a 30-day option to purchase up to an additional US$200 million principal amount of the Notes. The Company intends to use the net proceeds from the Notes Offering for the enrichment of content offerings, research and development, and general corporate purposes. The Company plans to use an equivalent amount of the net proceeds from the Notes Offering to...

Continue reading

Immuneering Announces Participation in December Investor Conferences

Highlighting proprietary pipeline of oncology drug candidates that spare healthy normal cells by modulating signaling dynamics to focus therapeutic efficacy against tumor cells CAMBRIDGE, Mass., Nov. 18, 2021 (GLOBE NEWSWIRE) — Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular signaling dynamics, today announced that Ben Zeskind, Ph.D., Co-Founder, President and Chief Executive Officer of Immuneering, Biren Amin, MBA, Chief Financial Officer and Brett Hall, Ph.D., Chief Scientific Officer, will participate in several December investor conferences to share commentary with investors around the Company’s pipeline, platform and business strategy. Immuneering will present virtually at the following...

Continue reading

Grocery Outlet Holding Corp. Announces Participation In Morgan Stanley’s Virtual Global Consumer & Retail Conference

EMERYVILLE, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) — Grocery Outlet Holding Corp. (NASDAQ: GO) (“Grocery Outlet” or the “Company”) today announced that the Company will be participating in a virtual fireside chat at Morgan Stanley’s Virtual Global Consumer & Retail Conference on Thursday, December 2, 2021 at 2:25 PM ET. Attending for Grocery Outlet will be Eric Lindberg, Chief Executive Officer, RJ Sheedy, President, Charles Bracher, Chief Financial Officer and Arvind Bhatia, Vice President of Investor Relations. The presentation will be webcast live over the internet and can be accessed at https://investors.groceryoutlet.com/news-and-events/investor-calendar. An online archive will be available for a period of 30 days following the presentation. About Grocery Outlet: Based in Emeryville, California, Grocery Outlet is a high-growth,...

Continue reading

Marijuana Company of America, Inc. Reports its Highest Quarterly Revenue Since Inception for Q3 2021

LOS ANGELES, CA, Nov. 18, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Marijuana Company of America, Inc. (OTC: MCOA) (“the Company”), a diversified company with operations and investments throughout the cannabis industry, today announced its financial results for the third quarter and nine months ended September 30, 2021.  This is the Company’s highest quarterly revenue reported in its history. Total revenues for the three months ended September 30, 2021 and 2020, were $442,178 and $53,195, respectively, an increase of $388,983. This increase is mainly attributable to $407,246 of product sales from our new acquisition of our distribution company called cDistro, which began full operations during the quarter ended September 30, 2021. In addition, MCOA also recorded $12,581 in equipment lease revenues to a cannabis distributor...

Continue reading

Scandinavian Tobacco Group A/S acquires majority stake in Italian cigar company

Press release                                                                                   Copenhagen, 18 November 2021Scandinavian Tobacco Group A/S acquires majority stake in Italian cigar companyScandinavian Tobacco Group A/S has today completed the acquisition of a majority stake in Moderno Opificio del Sigaro Italiano, MOSI – an Italian cigar company with approximately 40 employees and production facilities in Orsago in the northern part of Italy. MOSI was founded in 2013 by Mr. Cesare Pietrella. The company produces high quality traditional Italian machine-rolled cigars with a blend of Italian and American Kentucky tobaccos, grown on plantations in Northern Italy and in the United States. With a small exclusive offering under the brand “Ambasciator Italico”, MOSI has gained a market share of approximately 9%...

Continue reading

Santa Fe Gold completes purchase of mill site and signs Mineral Exploration and Option Agreement with Texas Minerals Resources, Corp.

ALBUQUERQUE, N.M., Nov. 18, 2021 (GLOBE NEWSWIRE) — Santa Fe Gold Corporation (“Santa Fe Gold,” or the “Company”) is pleased to announce the closing on the acquisition of an ideally situated property in Duncan, Arizona for the construction of our planned ore processing mill. The site is situated approximately 15 miles from our mines located in New Mexico and was chosen because the regulations and permitting in Arizona are more favorable for the operations as planned when construction at the site is completed. The mill site currently consists of 11.23 acres, has truck scales and two building structures. The Company has received the completed report from the retained engineering firm in Denver, Colorado. The report provides the design for the mill layout, necessary equipment and the testing of the process to maximize recovery of...

Continue reading

Itamar Medical Reports Third Quarter 2021 Financial Results

– Revenues Increased 23% Year-over-Year to $13.6 Million – – U.S. WatchPAT™ Revenues Increased 27% Year-over-Year to $11.3 Million – CAESAREA, Israel, Nov. 18, 2021 (GLOBE NEWSWIRE) — Itamar Medical Ltd. (Nasdaq and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today reported unaudited financial results for the third quarter of 2021. “Third quarter results represent the strong traction our WatchPAT™ platform technology has gained entering the second half of 2021. Growth in the U.S. continues to outpace our overall growth on top of expanding adoption in the markets we serve throughout Europe and the rest of the world,” said Gilad Glick, President and Chief Executive Officer of Itamar Medical. Third...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.